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ABSTRACT 
Inter-kingdom Recognition of Norepinephrine by E. Coli: Identification of the Receptors 
Involved in Chemotaxis. (August 2012) 
Dae Nyun Kim, B.S.; M.S., Yonsei University, Seoul, Korea 
Chair of Advisory Committee: Dr. Arul Jayaraman 
 
There are approximately 1014 bacteria belonging to nearly 1000 different species in 
the human gastrointestinal (GI) tract that co-exist with host cells. Within the GI tract, 
signaling molecules secreted by both eukaryotic and prokaryotic cells are abundant. 
Recent studies have shown that both bacteria and human cells recognize and respond to 
the signals from each other, presumably to gain a competitive advantage. The cross-
recognition of signals is known as Inter-kingdom (IK) signaling and this phenomenon is 
considered to be important in the onset of infections in the GI tract. Of the eukaryotic 
signaling molecules present in the GI tract, the neuroendocrine hormone norepinephrine 
(NE) is considered to be important in the context of infections as NE is produced at very 
high concentration in the intestine under post traumatic stress, is known to increase 
bacterial virulence and infection, and has also been shown to be a potent chemoattractant 
for GI tract pathogens such as enterohemorrhagic E. coli (EHEC). The focus of this 
study is on elucidating the mechanisms underlying the recognition and chemotaxis of 
bacteria towards NE. 
While chemotaxis has been typically investigated in the context of bacteria moving 
towards a metabolizable source (e.g., amino acids), chemotaxis is potentially important 
in the onset of infections in the human GI tract. In this study we use a microfluidic plug 
 iv
assay to investigate the receptor and mechanism utilized by a model bacterium 
Escherichia coli in its chemotactic response to NE. A series mutant of E. coli RP437 
strains of knockouts for four MCP-encoding genes was used in this study. The results 
from the microfluidic plug assay were then confirmed quantitatively by capillary assay. 
We have shown that Tsr receptor is necessary for chemotaxis of NE for E. coli 
RP437, and attraction of E. coli towards NE may require an additional receptor. Results 
from the priming experiments suggest that exposure to NE may result in the de novo 
expression of co-receptor(s) that are crucial to chemotaxis towards NE. The requirement 
for high cell density also suggests the possibility that NE per se may not be an attractant 
for E. coli, but could be a precursor that is modified into a chemoattractant by cells. 
These results are expected to further our understanding of bacterial chemotaxis and its 
role in bacterial colonization and infection of the human GI tract. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Background 
 The human GI tract is a nutrient-rich environment where approximately 100 trillion 
(1014) microbes from up to 1000 distinct bacterial species exist, which is approximately 
10-times greater than the number of cells in the human host (1). Therefore, the gut 
microbiome is one of the most complex microbial ecosystems, in which a diverse 
population of bacteria co-exists with human cells (2). The gut microbiome contains 
symbionts (or probiotics) that have known health-promoting functions, commensals, that 
are permanent residents that provide no benefit or cause no harm to the host (3), and 
pathobionts (or pathogens) that have the potential to induce pathological changes in the 
human host (4). Symbiotic gut bacteria supply essential nutrients, metabolize 
compounds in the food, defend against colonization by foodborne pathogens and by 
opportunistic-pathogens, and contribute to the development of overall health of humans 
(3). 
Bacterial chemotaxis is one of the simplest and best-understood behaviors at the 
molecular level. It is the biasing of movement towards regions that contain higher 
concentrations of beneficial, or lower concentrations of toxic, chemicals. The in vivo 
________________________ 
This dissertation follows the style of Proceedings of the National Academy of Sciences 
of the United States of America. 
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relevance of bacterial chemotaxis is self-evident. Chemotaxis towards epithelial cells in 
the GI tract in response to small molecules has been shown to be a crucial first step in 
infection (5). Because the migration to host cell surfaces is the crucial first step for many 
pathogens, chemoeffectors in the microenvironment where infections occur have been 
proposed to be determinants of infection (6). For example, Helicobacter pylori has been 
described to use chemotaxis for migrating to gastric epithelial cell surfaces (7, 8).  
Although recent reports that chemotaxis affects the virulence of pathogenic bacteria (7-9) 
and the observation that molecules such as hormones present in the GI tract influence 
different phenotypes associated with virulence and chemotaxis (5, 10, 11), there is very 
little information on how the chemotaxis response to specific molecules leads to 
establishment of infections in living organisms.  
Several signaling molecules within the GI tract have been shown to affect chemotaxis 
and virulence (5, 10, 11). Of these hormones such as norepinephrine, dopamine, and 
serotonin that are produced locally in the GI tract via the enteric nervous system are the 
best studied (12-15). NE is a major neurotransmitter of the sympathetic nervous system 
that enervates the GI tract, and L-dopa, which is a precursor in the NE biosynthesis 
pathway, is a component of food, such as bananas (14, 16). With more than 100 million 
nerve endings enervating the smooth muscle that underlies the intestinal epithelium 
throughout the GI tract (12, 13), local concentrations of NE in the GI tract lumen can be 
extremely high. The NE concentration becomes elevated in stress conditions (17) and 
that susceptibility to infections increases during these states. About 50% of all the NE 
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found in the body is synthesized in the GI tract (12, 18). Therefore, it is likely that NE 
can spill-over into the lumen, where it could be sensed by different pathogens.  
 NE has been reported to be a chemoattractant for enterohemorrhagic E. coli (10). 
However, the receptor(s) involved in NE sensing have not yet been identified. This work 
focuses on identifying the receptor(s) involved in the chemo-sensing of NE in E. coli. A 
non--pathogenic lab strain E. coli RP437 will be used as a model strain for investigating 
the chemotaxis of EHEC towards GI tract molecules, since both non-pathogenic E.  coli  
and  EHEC  possess  the  same  five chemoreceptors Tar, Tsr, Tap, Trg, and Aer with  a  
high  degree  of  gene and protein sequence  homology (19). Moreover, E. coli RP437 is 
well characterized, has been extensively used for chemotaxis studies, and a mutant 
library with different combinations of deleted chemoreceptors is also available (20). 
 
1.2 Motivation 
 Infections caused by foodborne pathogens affect millions of people and kill 
thousands in the United States alone.  The Center for Disease Control (21) estimates for 
2011 show that food-borne infections affect approximately 47.8 million Americans 
every year, with 128,000 hospitalizations and 3,000 deaths (21). Foodborne pathogens 
such as Salmonella spp., EHEC, enteropathogenic E. coli (EPEC), Campylobacter spp., 
and Staphylococcus aureus are the most common causes of enteric infections. Enteric 
infections are characterized by diarrhea, abdominal discomfort, nausea and vomiting, 
and anorexia, and sometimes lead to infection in the systemic circulation and death. In 
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United States, estimation of $152 billion/year, including the medical costs (hospital 
services, physician services, and drugs), quality-of-life losses (deaths, pain, suffering, 
and functional disability), and costs to others in society (e.g. costs to insurance 
companies that pay medical expenses) is associated with foodborne illness alone (22). 
Some enteric infections, such as the ones caused by EHEC, cannot be treated by 
antibiotics because of the possibility of aggravating the infection due to enhanced release 
of shiga toxins that are critical for the infection (23); this requires doctors to employ 
alternate treatment approaches such as fluid and electrolyte administration to limit the 
severity of symptoms (24, 25). 
 
1.3 Research importance, objectives, and novelty  
 Because the host cells and bacteria in the GI tract are in close proximity, a pathogen 
entering the GI tract are exposed to molecules produced by the host mucosal cells as 
well as by the commensal bacteria that reside in the GI tract. It has been proposed that 
the pathogens utilize these molecules to identify the favorability of the 
microenvironment for colonization and further to infection. These molecules include 
those used in bacterial quorum sensing or cell-cell communication and metabolites 
produced during normal bacterial growth. Eukaryotic signals produced in situ in the 
intestine of the host include hormones such as norepinephrine (NE), epinephrine, 
dopamine, and serotonin (26) and small molecules such as adenosine (27). Importantly, 
it has been shown that molecules produced by bacteria in the GI tract are recognized by 
5 
 
host cells and vice versa (26). Therefore, the recognition of the produced molecules by 
cells of different kingdoms and the high abundance of these molecules are thought to be 
a major contributor to the initiation and development of pathogen infections in the GI 
tract. However, previous studies have typically focused on either the response of 
pathogenic bacteria to bacterial signals, or on the role of hormones in the context of host 
GI tract physiology. Importantly, the role of these hormones in chemotaxis and initiating 
infections are not fully understood. Specifically, the mechanism(s) underlying 
chemotaxis in the GI tract are not fully known, and evidence that firmly establishes the 
role of chemotaxis in colonization is limited. Thus the proposed experiments are novel 
because bacterial chemotaxis has not been studied from the view point of IK signaling 
and this work will be the first time providing a molecular basis for this IK interaction.  
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CHAPTER II 
LITERATURE REVIEW 
 
2.1 Bacterial Chemotaxis 
2.1.1 Escherichia coli chemotaxis  
 Chemotaxis, or the movement toward or away from chemicals, is a universal 
attribute of motile cells and organisms (28).  E. coli cells swim toward amino acids (e.g., 
serine, aspartic acid), sugars (maltose, ribose, galactose, glucose), dipeptides, 
pyrimidines and electron acceptors (oxygen, nitrate, fumarate) (29-31). Cells also swim 
away from potentially harmful chemicals, such as alcohols and fatty acids, but repellent 
responses have not been as extensively studied (32). In the absence of any stimulating 
chemical gradient, E. coli swims in a random walk pattern produced by alternating 
episodes of counter-clockwise (CCW) and clockwise (CW) flagellar rotation (33).  In an 
attractant or repellent gradient, the cells monitor chemoeffector concentration changes as 
they move and use that information to control the probability of the next tumbling event 
(34).  These flagellar responses extend runs that take the cells in favorable directions 
(toward attractants and away from repellents), resulting in net movement toward 
preferred environments.  E. coli senses chemoeffector gradients in a temporal fashion by 
comparing the current concentrations to those encountered over the past few seconds of 
travel.  Out of the five chemoreceptors in E. coli, four (Tsr, Tar, Tap, and Trg) are 
transmembrane receptors. These methyl-accepting chemotaxis proteins (MCPs) have 
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periplasmic ligand binding sites and conserved cytoplasmic signaling domains (34) (Fig. 
2.1) and record the cell's recent chemical past (ligand concentration) in the form of 
reversible methylation of specific glutamic acid residues in the cytoplasmic signaling 
domain of the chemoreceptors (34). Whenever the ligand bound to the periplasmic 
domain of the MCP’s dissociates from the receptor, the flagellar motor response stops 
until a new ligand binds to the MCP (34). A fifth MCP-like protein, Aer, mediates 
aerotactic responses by monitoring redox changes in the electron transport chain (34).  
Aer undergoes sensory adaptation through a poorly understood, methylation-independent 
mechanism. The five MCP-family receptors in E. coli utilize a common set of 
cytoplasmic signaling proteins to control flagellar rotation and sensory adaptation (Fig. 
2.1) (34).  Receptor CheW and sensor kinase CheA generate receptor signals in the form 
of phosphoryl groups to CheY and CheZ which control motor responses in response to 
chemical stimuli; CheR and CheB regulate MCP methylation state (34). 
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Fig. 2.1. Signaling components and circuit logic of E. coli.  Five E. coli 
chemoreceptors Tsr, Tar, Tap, Trg, and Aer are shown along with their chemoeffector 
ligands serine, maltose/ aspartate, dipeptides/pyrimidines, galactose/ribose, and oxygen 
respectively. All five receptors employ a common set of cytoplasmic signaling proteins, 
CheW and CheA, which interact with cytoplasmic domain of chemoreceptor to form 
stable ternary complexes that generate stimulus signals in the form of phosphoryl groups. 
CheY transmits those signals to the flagellar motors, CheZ controls their lifetime; CheR 
(methyltransferase) and CheB (methylesterase) regulate MCP methylation state. 
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2.1.2 Methods for studying bacterial chemotaxis 
 There are several established qualitative and quantitative techniques for assaying 
bacterial chemotaxis as reviewed by Englert et al. (14). The most commonly used 
techniques are highlighted below. 
 
2.1.2.1 Swim and swarm plate assays  
 Chemotaxis of bacteria toward a chemoeffector that can be metabolized can be 
measured using agar plate assays (14). For swim plate assays, motility medium 
containing low agar concentrations (0.25 to 0.4%) are used (14). The bacteria move in 
the aqueous channels inside the agar, and these channels are large enough for them swim 
through. As the colony grows, it metabolizes any attractants it can which causes the 
formation of a spatial concentration gradient in the agar. As a result, the cells migrate 
outward towards higher concentrations (14). By measuring the size of the sharp ring 
formed by cells at the edge of the steepest gradient, the strength of attraction can be 
measured (14). 
 A variation on the swim plate method is the swarm assay. Motility medium 
containing higher concentrations of agar (0.5% to 0.7%) are used, and the cells swim 
through the aqueous layer that forms on the agar surface (35). Swarming cells typically 
produce more, longer flagella (35). Both swimming and swarming assays cannot be used 
for measuring repellent taxis, and chemotaxis toward chemoeffectors that cannot be 
metabolized by the cells (14). 
10 
 
 
2.1.2.2 Capillary assays  
 This assay was developed by Adler et al. (29) and is widely used for investigating 
chemotaxis. Chambers on the order of 1 cm2 made from plastic o-rings with a 60o cut 
and 1 mm in height are loaded with a suspension of highly motile bacteria in chemotaxis 
buffer to create a pond (Fig. 2.2). A 1 mm capillary is sealed at one end and filled with 
several μl of an attractant at the desired concentration at the other. The capillary is then 
inserted into the pond and incubated at the desired temperature for 45 minutes. The 
chemoeffector in the capillary will diffuse out into the chamber creating a gradient that 
the can be sensed by the bacteria around the opening of the capillary. The bacteria will 
migrate into the capillary if the chemoeffector is an attractant. The capillary is then 
removed, and the contents placed into dilution buffer. Dilutions are plated on nutrient 
agar and colony counts enumerated, which allow the number of cells entering the 
capillary to be calculated. These numbers can then be used to compare the chemotactic 
response and strength of response to various compounds. Although the capillary assay 
can be used for measuring repellant taxis, the results are not nearly as sensitive as those 
for attractants. 
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Fig. 2.2. Experimental setup for the capillary assay.   
1. Glass slide 
2. Plastic o-rings cut at one end 
3. Ponds containing highly motile cells 
4. Capillary tube containing chemoeffector 
5. Capillary tube with cells along with the chemoeffector 
 
  
 
 
  
  
1 
2 
3 4 
5 
Time = 0 minutes 
Time = 45 minutes 
12 
 
2.2 Stress hormones - norepinephrine (NE)  
 NE is a catecholamine neurotransmitter (stress hormone) that is normally produced 
in the GI tract through the enteric nervous system (36, 37) and is important in GI-tract 
infections. The concentration of NE increases during early sepsis (38), and NE has been 
shown to stimulate the growth of several Gram-negative and -positive bacteria that are 
present in the intestinal lumen (39). Alverdy and co-workers (6) have correlated the 
increased NE in the luminal contents of mice after a 30% hepatectomy to increased 
expression of the P. aeruginosa virulence determinant PA-I lectin and gut-derived sepsis. 
The NE released in the GI tract during stress has also been reported to influence the 
virulence and infection of other GI tract pathogens. Bansal et al. (9) and others (40, 41) 
have shown that NE increases EHEC O157:H7 attachment and colonization to epithelial 
cells and colonic mucosa, respectively. NE also enhances the growth, motility, and 
invasiveness of Campylobacter jejunii (42), the expression of the K99 pilus adhesin 
virulence-related factor in ETEC (43), EHEC O157:H7 virulence gene expression (9, 44), 
and EHEC O157:H7 chemotaxis, motility, and biofilm formation (9). 
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CHAPTER III 
INVESTIGATING CHEMOTAXIS TOWARDS NOREPINEPHRINE USING 
MICROFLUIDIC PLUG ASSAY 
3.1 Overview 
Noreponephrine, one of the eukaryotic signaling molecules present in the GI tract, is 
considered to be important in the context of GI tract infections. NE is produced at very 
high concentration in the intestine under post traumatic stress and is known to increase 
bacterial virulence and infection, and has been shown to be a potent attractant for GI 
tract pathogens. Bacteria can sense and respond to such attractants using cell surface 
receptors. By comparing the current concentration of a specific molecule and the 
concentration detected a few seconds earlier, bacteria determine the net direction of 
movement to approach attractants or to avoid repellents. This movement is potentially 
important in the initiation of pathogenic bacteria attachment and infection.. In this study 
we use a plug-flow assay to show that E. coli sense NE through the chemoreceptor Tsr, 
and elucidate the molecular mechanisms underlying the chemotaxis of these pathogen 
towards NE. Through these results we expect to further our understanding of bacterial 
chemotaxis and its role in bacterial colonization and infection of the human GI tract.  
 
3.2 Introduction 
Escherichia coli is a serious cause of gastroenteritis (23). This bacterium is 
noteworthy because a few, but significant, number of infected people develop the 
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haemolytic uraemic syndrome, which is the most frequent cause of acute renal failure in 
children in the Americas and Europe (23). Many infections of E. coli could be prevented 
by the more effective application of evidence-based methods, which is especially 
important because once an infection has been established, no therapeutic interventions 
are available to lessen the risk of the development of the haemolytic uraemic syndrome 
(23). Moreover, a recent study (9) has shown that E. coli can utilize eukaryotic and 
prokaryotic signals, such as epinephrine (45) and NE, to “sense” and detect the 
appropriate location (i.e., large intestine) prior to colonization. Sensing of EPI and NE 
by E. coli could be the first step in a sequence of events leading to infection, as 
phenotypes such as adherence and colonization, which are downstream of chemotactic 
recognition and important for infection, are also up-regulated by EPI and NE (9). Indeed, 
catecholamines have been shown to increase the adherence of E. coli to intestinal 
mucosa in different in vivo models of infection (40, 41). The recognition of EPI and NE 
by E. coli are also in agreement with other reports on the regulation by EPI and NE of 
the expression of virulence genes and infection (46-48) and, together, suggest an 
important role for these molecules in E. coli infections. Although previous studies have 
shown that NE increases virulence and pathogenicity, the mechanisms through which 
NE impacts virulence of different bacteria are not fully understood. 
 The goal of this work was to investigate the sensing mechanism of NE by E. coli. 
From the lower concentration of 50 µM, representative of NE levels present in the GI 
tract during homeostasis that has been used in recent studies (49) to investigate the effect 
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of hormones on GI tract pathogens, to the higher concentration (200 µM) was used as 
representative of supra-physiological levels of NE likely to be encountered in the GI 
tract during catabolic stress was used in experiments. To our knowledge, this is the first 
report investigating the sensing mechanism NE by E. coli. 
 
3.3 Materials and methods 
3.3.1 Bacterial strains, culture conditions, and growth media 
A series of knockouts for the four MCP-encoding genes of the E. coli strain RP437 
was used in this study. For unity of nomenclature, RP437 strain was called CV1, and the 
mutant series uses the CV designation. All combinations of single (four mutants), double 
(six mutants), triple (four mutants), and quadruple (one mutant) knockouts were made in 
the laboratory of Prof. Michael Manson, Department of Biology, Texas A&M University, 
to create the CV1 through CV16 strains. In this study, only CV1 - CV10, CV12, and 
CV13 was used. Details on the chemoreceptors present in each of these strains is given 
in Table 3.1. Tryptone broth (TB; 10 g/L tryptone and 8 g/L NaCl) was used to grow all 
strains. L-serine and L-asparctic acid were obtained from Fisher Scientific (Fair Lawn, 
NJ), and the L-(-)-Borepinephrine-(+)-bitartrate (NE) was obtained from Calbiochem 
(La Jolla, CA). 
The bacterial strains and plasmids used in this study are listed in Table 3.1 All 
strains were trasnformed with plasmid pCM18 that encodes for green fluorescent protein 
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(GFP). Different CV strains with plasmid pCM18 were grown overnight at 32°C in 
tryptone broth containing 150 µg/ml erythromycin.  
 
Table 3.1 Characteristics of the strains and plasmids used 
Strain or plasmid Genotype Resistancea 
Escherichia coli strains   
CV1 Chemotaxis wild type 
(same as RP437) 
Str 
CV2 CV1 △tap Str 
CV3 CV1 △trg Str 
CV4 CV1 △tar Str 
CV5 CV1 △tsr Str 
CV6 CV1 △trg-tap Str 
CV7 CV1 △tar-tap Str 
CV8 CV1 △tar-trg Str 
CV9 CV1 △tsr-tap Str 
CV10 CV1 △tsr-trg Str 
CV12 CV1 △tar-trg-tap Str 
CV13 CV1 △tsr-trg-tap Str 
TG1/pDS-Red Express Wild type; dead-cell control Amp 
   
Plasmids   
pCM18 GFP-expressing vector Erm 
pDS-RedExpress RFP-expressing vector Amp 
a. Str, streptomycin; Amp, ampicillin; Erm, erythromycin 
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3.3.2 Fabrication of the µPlug device 
Devices were fabricated using standard soft lithography procedures (50). Device 
drawings were made in AutoCAD or equivalent CAD software and a photolithography 
mask created from the CAD file using a high-resolution (>3000 dpi) printer (Advanced 
Reproductions, North Andover, MA). The device was created photolithographically 
using silicon wafer and SU-8 negative photoresist (Microchem Corp, MA). A 10:1 
mixture of PDMS prepolymer and curing agent was prepared and cured against the Si 
master. After curing for 4h at 85℃, the PDMS replica were removed from the master 
and the cell-inlet and agarose-inlet ports were made using a needle. The device was then 
oxidized in an oxygen plasma etcher (100 mTorr, 100 W, 40 sec) with a glass slide for 
40 s. Bringing the oxidezed PDMS and glass slide into conformal contact resulted in an 
irreversible seal between the PDMS mold and the glass slide. 
The μPlug assay (14, 51) is an improved version of the well-established plug-in-pond 
assay (32). It consists of a 15 X 15 mm square chamber with a height of ~75 µm. 
Agarose mixed with chemoeffector is introduced through a 1.5 mm diameter hole in the 
middle of the chamber. Two additional holes are punched with a blunt 19-gauge needle 
along the diagonal, one of which to introduce cells into the chamber, and the other to 
provide a vent as shown in Fig. 3.1. The gradient of chemoeffectors are formed by 
diffusion out of the plug. Depending on what the orientation of the cells are to the 
chemoeffector inside the plug, cells either move away (if repellent) or towards the plug 
(if attractant). (case of attractant is shown in cartoon in Fig. 3.1)  
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While the μPlug assay results provide whether the chemoeffector placed in the plug 
is an attractant or a repellent, it does not facilitate quantification of the extent of response 
towards or away from the chemoeffector. Furthermore, this assay is also prone to false 
positives as some cells may attach to the plug when being inserted into the chamber. 
There is also some variability in the number of cells (and hence, the apparent magnitude 
of response) because the cell density used in the assay cannot be rigorously controlled 
and more cells are typically observed near the cell port, with the density decreasing at 
distances farther from it. Although the results shown here are reproducible, it is always 
desirable to confirm the μPlug results with additional assays such as the capillary assay.   
 
Figure 3.1 Schematic of the modified mPlug assay. Both top and side views of the 
chamber are shown. GFP-labeled bacteria suspended in CB were introduced at the 
bacteria inlet, and the air outlet allowed escape of air. The agarose plug contained CB 
plus L-serine or NE at the desired concentration. The plug was visualized by addition of 
5% bromophenol blue to provide optical contrast. Gradients in the bacterial suspension 
form by diffusion of attractant out of the plug. Gradients develop rapidly and are 
relatively steep. The cartoon shows the distribution of GFP-labeled cells when they are 
first introduced (t = 0 min) and at the end of the experiment (t = 30 min). 
  
 
 
 
  
 
 
Top view Side View 
 
 
 
  
t = 0 min 
t = 30 min    
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3.3.3 Growth of bacteria for the µPlug assay 
Bacteria were prepared for chemotaxis assays as described earlier in our prior work 
(14).  Briefly, The overnight culture was diluted to a turbidity of 0.05 at 600nm in 25 ml 
of TB without erythromycin and then grown to mid-logarithmic phase (turbidity of ~ 0.5 
at 600 nm) at 32°C. Prior to preparing cells for the assay, bacterial motility was visually 
examined using phase-contrast microscopy to ensure robust motility and normal run-
tumble swimming behavior. Cells were centriguged at 400 x g for 10 minutes, and the 
aliquot was discarded. Chemotaxis buffer (CB; phosphate-buffered saline, 0.1 mM 
EDTA, 0.01 mM L-methionine, and 10 mM D,L-lactate)  was added to the cells so that 
the concentration of the cells was twice of the denity before centrifugation.  
Cells were mixed with an approximately equal number of dead TG1 cells that had 
expressed red fluorescent protein (RFP) from plasmid pDS-Red Express (Clonetech, 
Mountain View, CA). The dead RFP-containing cells served as a control to visualize any 
mixing due to turbulence within the microfluidic chamber. 
For experiments involving priming of cells with NE, cells were exposed to a 2 µM of 
NE 30 minutes prior to harvest of cells. Control cells were primed with CB.  A fresh 
stock of NE was used for all experiments.  
 
3.3.4 µPlug assay  
The agarose plug was made by melting 20 mg low-melting-temperature agarose in 
950 µL of CB and 50 µL of 5% bromophenol blue solution (to provide optical contrast) 
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at 70°C. The temperature of the agarose was reduced to 55°C, and chemoeffector was 
added to the final concentration desired and thoroughly mixed. An 8 µL aliquot of the 
agarose mixture was introduced into the µPlug device via the center hole. The device 
was allowed to sit for 5 min to cool to room temperature. The mixture of GFP-
expressing (live) and RFP-expressing (dead) cells was introduced gently via one of the 
corner holes until the chamber was  full, taking care to avoid air bubbles. Green and red 
fluorescent images of the cells around the plug were taken immediately after the device 
was placed on the microscope stage and after 30 min at room temperature (~23oC). The 
uniform distribution of red cells was used to ensure that no bulk flow had occurred.  
 
3.3.5 Capillary assays 
 Capillary assays were performed as previously described (29) except that plastic 
gaskets of the proper diameter and thickness were used to create the chamber, or “pond.”. 
Capillaries contained either CB alone or CB with the indicated concentration of L-serine, 
L-asparctic acid, or NE. The assay was run for 45 min at 32oC, and the number of cells 
entering the capillary was determined by plating dilutions of the capillary contents on 
LB agar containing 50 mg/mL streptomycin and counting colonies after 24 h incubation 
at 37oC. While this assay is simple, provides reproducible results, and the diffused 
gradients of a capillary has been mathematically characterized (52, 53), the sensitivity of 
this assay is somewhat limited because of the relatively low numbers of cells that are 
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exposed to a detectable concentration gradient, and the concentration gradient becomes 
shallower over time until it finally disappears. 
 
3.3.6 Preparation of bacteria for the capillary assay 
The protocol for growth of bacteria was identical to that for the µplug assay, except 
that CB was added so that the concentration of the cells was decreased 10-fold than 
before the centrifugation. For experiments with higher concentration of cells in the pond, 
the cell density was increased two-fold. In case priming was involved, 2 µM of NE were 
added to the cells to be primed 30 minutes prior to harvest of cells. 
 
3.4 Results 
3.4.1 Response of wild-type cells 
The responses of E. coli strain CV1 (RP437) and its isogenic tsr mutant derivatives 
are shown in Fig. 3.2. In the absence of NE in the plug, CV1 cells distributed themselves 
randomly (Fig. 3.2(a)). However, when CV1 cells were exposed to plugs containing 200 
mM L-serine or 200 mM NE, they exhibited strong attractant responses, as shown by the 
accumulation of bacteria at the agarose plug-liquid interface (Fig. 3.2(b) and (c)) 
confirming that NE is indeed an attractant to the cells. 
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3.4.2 Response of cells lacking different chemoreceptors 
Strains CV2 (CV1 Dtap), CV3 (CV1 Dtrg), and CV4 (CV1 Dtar) responded to L-
serine and gave a positive response to NE as well (Fig. 3.3). However, strain CV5 (CV1 
Dtsr) did not respond to either L-serine or NE. These results led to the conclusion that 
Tsr, which is the receptor required for taxis towards L-serine, is involved in NE sensing. 
 
 
 
 
 
 
 
(a) (c) (b) 
(a) (c) (b) 
Figure 3.2 Chemotatic response of CV1(RP 437) (a) Wild-type (CV1) cells in the 
absence of any attractant in the plug. (b) Distribution of wild-type (CV1) cells with 
200 mM L-serine in the plug. (c) wild-type (CV1) cells with 200 mM NE in the plug. 
Figure 3.3 Chemotactic responses to NE in the µPlug assays. Figures show the 
results of (a) Dtap (CV2), (b) Dtrg (CV3), (c) Dtar (CV4) cells with 200 mM NE in the 
plug. 
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To confirm that the Tsr is the receptor solely responsible for the detection of NE, the 
mutant with only Tsr (CV 12) was used . Strain CV12 (CV1 Dtar-tap-trg), which has Tsr 
as its only functional receptor (other than Aer), responded to L-serine (data not shown) 
but not NE (Fig. 3.4(a)), showing that Tsr receptor by itself is not sufficient for NE 
chemotaxis in E. coli. 
We then determined if a second receptor is required for chemotaxis towards NE. 
This experiment was done using 5 different strains with double knockouts - strains CV6 
(CV1 Dtrg-tap), CV7 (CV1 Dtar-tap), CV8 (CV1 Dtar-tag), CV9 (CV1 Dtsr-tap), and 
CV10 (CV1 Dtsr-trg). Fig. 3.4(b)-(f) shows that strains with at least one additional 
receptor other than Tsr shows attraction to NE. Of the 5 strains with double knockouts, 
only strains CV6, CV7, and CV8, which all have Tsr and one other receptor (Tar, Trg, 
and Tap, respectively) are attracted to NE.  
 
3.4.3 Effect of priming 
 It is well established that pre-exposure to specific ligands prior to testing their 
chemotactic response increases the extent of chemotaxis observed (54, 55).  For example, 
maltose chemotaxis requires that cells be exposed to maltose, as this leads to expression 
of the maltose binding protein that binds with the ligand and the Tar chemoreceptor. 
Therefore, we tested the effect of priming cells with NE prior to NE chemotaxis (56). 
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Exposing the wild-type CV1 cells to NE (Fig. 3.5(a) and (b)) and L-serine (data not 
shown) did not result in a significant increase in the extent of chemotaxis.  However, 
priming with NE prior to chemotaxis led to a marginal chemotaxis response in strain 
CV12. However, the extent of attraction was weaker than that observed with CV1. 
 
 
 
 
Fig. 3.4. Chemotactic responses of triple-knockout strain CV5 and double-knockout 
strains to NE in the µPlug assays. Figures show the results of (a) Dtar-tap-trg (CV12) 
(b) D trg-tap (CV6), (c) D tar-tap (CV7), (d) D tar-trg (CV8), (e) D tsr-tap (CV9), and (f) 
△ tsr-trg CV10 cells with 200 mM NE in the plug. 
(e) 
(b) 
(c) (d) 
(f) 
(a) 
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3.4.4 Capillary assay confirmation of plug assay results 
 Capillary assays (29) were used to quantitatively determine the strength of the NE 
chemotaxis response.  As expected from the mPlug assay results, CV1 cells accumulated 
in capillaries containing L-serine or NE (Fig. 3.6), and CV5 (Dtsr) cells did not 
accumulate in capillaries containing either L-serine or NE . Thus, the conclusions from 
the Plug assay on the requirement of Tsr f  or NE chemotaxis were confirmed. 
From the plot of the number of accumulated cells in the capillaries with 
chemoeffectors, L-serine and 500 μM and 5000μM NE, we can see that there is no 
significant increase in accumulation of CV1 and CV12 cells in capillaries containing NE, 
either with priming or without priming (Fig. 3.6(a)). This lack of accumulation confirms 
the conclusions from the second set of the μplug assay on the hypothesis of requirement 
of a second receptor. However, when the experiment was carried out with approximately 
10 times more cells in the capillary than the normal protocol, significant accumulation of 
CV1 and CV12 cells in NE capillaries are observed (Fig. 3.6(b)). The effect of priming 
can also be seen in Fig. 3.6(b), where almost 2-fold increase in the number of cells is 
observed with the normal cell density and up to more than 3-fold increase with the NE 
sample in case of high cell density protocol. 
 
 
 
 
 
26 
 
 
 
 
 
Fig. 3.5. Effect of priming on chemotactic  responses of CV1, CV5, and CV12 to NE 
in the µPlug assays. Figures show the results of (a) CV1 with priming (b) CV1 without 
priming, (c) CV5 with priming, (d) CV5 without priming, (e) CV12 with priming, and (f) 
CV12 with priming with 200 mM NE in the plug. 
  
(e) 
(b) 
(c) (d) 
(f) 
(a) 
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Figure 3.6 Comparison of the responses of cells to L-serine and NE in the capillary 
assay. (a) Number of primed and non-primed CV1 and CV12 cells, and (b) primed and 
non-primed CV12 in experiment carried out from higher number of cells, exposed to L-
serine, 500μM, and 5000μM norepinephrine. (‘*’ indicate statistical significance with 
respect to the control determined using the Student t-test at p < 0.05.) 
(b) 
(a) 
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CHAPTER IV 
DISCUSSION, SUMMARY, AND CONCLUSIONS 
 
4.1 Discussion 
  Our data suggest that of the four MCP’s of E. coli, Tsr has a major role in 
detection of NE. Since NE is derived from the amino acid tyrosine, may interact with a 
site that is identical to, or at least overlaps with, the known serine-binding site. Tsr 
analogues have been reported in many bacterial species including enteric pathogens (57), 
and it is possible that the response to NE is mediated through Tsr in the pathogenic 
bacteria as well. 
Sensing of NE by E. coli could be the first step in a sequence of events leading to 
infection, as phenotypes such as adherence and colonization, which are downstream of 
chemotactic recognition and important for infection, are also up-regulated by NE. Indeed, 
catecholamines have been shown to increase the adherence of E. coli to intestinal 
mucosa in different in vivo models of infection (40, 41). NE has been previously 
reported to induce bacterial growth (58), and there are reports in the literature that imply 
that NE might function as a siderophore (58). NE has been implicated as inducing 
expression of enterobactin and iron uptake in E. coli, suggesting that this is the 
mechanism involved in growth induction (59). However, the role of NE in bacterial 
pathogenesis seems to be more complex, because several reports suggested that this 
signal stimulates the growth of low cell density E. coli and induces the production of an 
autoinducer (AI) which, in turn, promotes E. coli growth (59). 
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From the observation in this study, the recognition of NE by E. coli seems to require 
the Tsr receptor, but this receptor by itself is not sufficient. This is supported by the 
µplug-assay results where a strain expressing Tsr and any other chemoreceptor responds 
to NE but a strain expressing only Tsr does not do so. It is not clear at this point if the 
second receptor is required for binding to NE or if it merely provides a critical density of 
chemoreceptors (i.e., a certain number of receptors in the receptor patch) in the receptor 
patch of E. coli (60, 61). The strains with knockout of receptor(s) used in this study have 
receptor patch with fewer receptors compared to the wild-type RP437 strain. For 
example, the size of the receptor patch for the CV12 strains is only a quarter of the size 
in CV1 strains (62). Thus, it is possible that that strain CV12 lacks a critical density of 
chemoreceptors in the receptor patch required for efficient chemotaxis.  
Cells are able to sense and respond to various external stimuli. To extend the 
working range of their sensory pathways, biochemical mechanisms allow for adaptation 
to persistent stimulation, resulting in only a transient response. The dynamics of 
adaptation are important as they often represent the cellular memory of previous 
environmental conditions, directly affecting cellular behavior (54, 63-65). Moreover, for 
some cases of chemotaxis, the chemoeffector does not directly bind to the respective 
receptor but interacts with the receptor through a binding protein that is expressed only 
in the presence of the chemoeffector. For example, maltose binding protein is expressed 
when cells are exposed to maltose, and the maltose-maltose binding protein binds to the 
aspartate receptor Tar (56). Similar observations have been made for the chemotactic 
response of galactose and ribose, where binding of the galactose-binding protein (66) 
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and ribose-binding protein (67) with Trg is required for chemotaxis to galactose and 
ribose, respectively. Recently, our lab demonstrated that the autoinducer-2 (AI-2) 
quorum sensing molecule binds to the periplasmic LsrB for chemotaxis but it is not clear 
if LsrB expression is induced upon exposure to AI-2. (68). Our data showing that 
priming cells with NE increases the chemotactic response suggest that pre-incubation 
may lead to the induction of any co-receptor(s) required for chemotaxis. While the effect 
of priming was not fully observable in the µplug assay, capillary assays confirmed that 
around 2-fold increase in attraction has occurred in case of primed strains. Moreover, 
when the experiment was carried out with a higher cell density, the effect of priming was 
further magnified, which suggest that the effect of priming could be a cell-density 
dependent metabolic response.  
For all the experiments in this work, cells were grown in tryptone broth (69). 
Compared to Luria Bertani medium (LB), TB lacks yeast extract which contains nucleic 
acids, lipids and other nutrients which are needed for bacterial growth (70). Also, prior 
to the assay, the bacteria are suspended in chemotaxis buffer (CB), which contains only 
10mM of D, L-lactate as the energy source. Given that the growth media and the buffer 
used provide the cells only minimal nutrients, it is possible that cell are constantly 
seeking other energy sources. Based on studies showing that aromatic compounds can be 
utilized by E. coli as carbon and/or nitrogen sources (71), it is intriguing to speculate that 
the increased response observed with NE priming  could be due to a response to a 
molecule that is produced during the biodegradation of NE by E. coli. This is also 
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consistent with studies showing that NE potentiates bacterial growth and induces 
expression of virulence determinants in E. coli (15, 72).  
 
4.2 Summary and conclusions 
We have shown that Tsr receptor is necessary for chemotaxis of NE for E. coli 
RP437, and attraction of E. coli towards NE may require an additional receptor. Results 
from the priming experiments suggest that exposure to NE may result in the de novo 
expression of co-receptor(s) that are crucial to chemotaxis towards NE. The requirement 
for high cell density also suggests the possibility that NE per se may not be an attractant 
for E. coli, but could be a precursor that is modified into a chemoattractant by cells (i.e., 
conceptually similar to  the idea proposed by Goldberg et al, (73)). 
 
4.3 Future work 
The hypothesis that increasing number of receptors of even a single Tsr receptor 
leads to enhanced chemotactic response to NE needs to be investigated further. 
Specifically, we will need to determine if a specific receptor (e.g., Tar) or binding site is 
required for chemotaxis towards NE or whether the attenuated response with the single 
receptor is due to a lack of sufficient receptor density in the receptor patch. This can be 
tested by using CV16 (lacks all four MCPs) and introducing plasmid pCAN24-Tsr into it. 
Since the expression of Tsr in this plasmid can be induced, by using different 
concentrations of IPTG, we can achieve different Tsr levels in CV16 cells. By 
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correlating the extent of chemotaxis to the level of Tsr induction, we can determine if 
additional receptor(s) are required.  
The plug assay used in this work provides a qualitative determination of chemotaxis 
but does not allow comparison of responses. For example, what is the extent of response 
with different levels of forced over-expression of Tsr? This can be addressed by using a 
microfluidic chemotaxis flow system developed in our lab (Fig 4.1(a)) (14). Such a 
model can be used to determine the optimum concentration needed for chemotaxis. This 
device will also allow us to study chemotaxis within the GI tract more effectively by 
simulating different flow patterns and profiles. 
Most importantly, the effect of priming should be investigated further to elucidate 
the mechanism underlying E. coli chemotaxis. The requirement for de novo synthesis 
can be investigated by adding a protein synthesis inhibitor and determining the extent of 
chemotaxis (Fig 4.1(b)). Similarly, we can also utilize the genome information available 
at the KEGG database (74) to identify potential molecules that can be generated from 
NE and the pathways that are involved.  
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Fig. 4.1. Future work.  (a) Schematic representation of the microfluidic device. The 
device consists of a gradient-mixing module and a chemotaxis observation module. The 
inset schematically depicts a gradient of a repellent molecule (gray) and bacteria 
migrating in response to it. (51) (b) A hypothetical NE binding periplasmic protein that 
may bind to NE and interact with the Tsr receptor.  
  
(a) 
(b) 
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